Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial

Odd Lilleng Gammelgaard, Sidse Ehmsen, Anne Marie Bak Jylling, Lene Sandberg, Alexei F Kirkin, Annette Raskov Kodahl, Henrik J Ditzel

Open source

DOI
10.1136/jitc-2025-012213
Published
2025-12
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-012213,
  title = {Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial},
  author = {Odd Lilleng Gammelgaard and Sidse Ehmsen and Anne Marie Bak Jylling and Lene Sandberg and Alexei F Kirkin and Annette Raskov Kodahl and Henrik J Ditzel},
  year = {2025},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2025-012213},
  url = {https://doi.org/10.1136/jitc-2025-012213}
}

RIS

TY  - JOUR
TI  - Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial
AU  - Odd Lilleng Gammelgaard
AU  - Sidse Ehmsen
AU  - Anne Marie Bak Jylling
AU  - Lene Sandberg
AU  - Alexei F Kirkin
AU  - Annette Raskov Kodahl
AU  - Henrik J Ditzel
PY  - 2025
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2025-012213
UR  - https://doi.org/10.1136/jitc-2025-012213
ER  - 

APA

Gammelgaard, O. L., Ehmsen, S., Jylling, A. M. B., Sandberg, L., Kirkin, A. F., Kodahl, A. R., & Ditzel, H. J. (2025). Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with chemotherapy in locally advanced or metastatic triple-negative breast cancer: the ImmunoBreast phase Ib clinical trial. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012213

Source records